Article Details

RTP's Locus Biosciences closes $35M Series B, investors include J&J and Tencent

Retrieved on: 2022-05-18 17:30:49

Tags for this article:

Click the tags to see associated articles and topics

RTP's Locus Biosciences closes $35M Series B, investors include J&J and Tencent. View article details on hiswai:

Excerpt

Locus technology focuses on the use of a bacteriophage discovery, synthetic biology and manufacturing platform. It develops precision CRISPR-enhanced ...

Article found on: wraltechwire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up